BT3:FRA
Lineage Cell Therapeutics Inc
0,82 €
arrow_upward
+1,23%(+0,0100) 1D
8. okt., 08:01:28 GMT +2 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za BT3 …
Odpri
0,82 €
Visoka
0,82 €
Nizka
0,82 €
Tržna kapitalizacija
252,34 mio.
Povprečni promet
37,00
Promet
0,00
52-tedenski najvišji tečaj
1,69 €
52-tedenski najnižji tečaj
0,78 €
Št. zaposlenih
75
Odpri
0,82 €
Visoka
0,82 €
Nizka
0,82 €
Tržna kapitalizacija
252,34 mio.
Povprečni promet
37,00
Promet
0,00
52-tedenski najvišji tečaj
1,69 €
52-tedenski najnižji tečaj
0,78 €
Št. zaposlenih
75
Novice
Iz spletnih virov in novičarskih partnerjev
Delo.si
·
pred 22 urami
Borze v rdečem, hipoteke pri 7,5 odstotkih, evro proti 17-mesečnemu dnu
Business Insider
·
pred 20 minutami
What I saw as David Ellison's Skydance rang the opening bell at the New York Stock Exchange
www.marketscreener.com
·
pred 49 minutami
Wah Fu Announces Corporate Name Change to Wah Fu Education & Technology Group Limited and Nasdaq Ticker “WAFU” Unchanged
Simply Wall Street
·
pred 46 minutami
CEO Change Could Be A Game Changer For Adeia (ADEA)
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Vizitka: Lineage Cell Therapeutics Inc